{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,3,20]],"date-time":"2023-03-20T12:23:05Z","timestamp":1679314985071},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.jbspin.2010.12.007","type":"journal-article","created":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T09:35:45Z","timestamp":1296120945000},"page":"235-240","source":"Crossref","is-referenced-by-count":10,"title":["Actuality of juvenile dermatomyositis"],"prefix":"10.1016","volume":"78","author":[{"given":"Amine","family":"Zouagui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Abourazzak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mounia Lakhdar","family":"Idrissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima Zohra","family":"Souilmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Chaouki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Atmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelhak","family":"Bouharrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moustapha","family":"Hida.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2010.12.007_bib0005","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/art.11122","article-title":"US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry","volume":"49","author":"Mendez","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0010","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/rheumatology\/kel099","article-title":"The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland) \u2013 clinical characteristics of children recruited within the first 5 yr","volume":"45","author":"McCann","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0015","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jpeds.2005.10.032","article-title":"Duration of illness is an important variable for untreated children with juvenile dermatomyositis","volume":"148","author":"Pachman","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1067\/mjd.2001.113686","article-title":"Juvenile dermatomyositis: a retrospective review of a 30-year experience","volume":"45","author":"Peloro","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1590\/S0021-75572008000100012","article-title":"Risk factors associated with calcinosis of juvenile dermatomyositis","volume":"84","author":"Sallum","year":"2008","journal-title":"J Pediatr (RioJ)"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0030","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1090-3798(98)80021-4","article-title":"Childhood dermatomyositis: clinical course of 36 patients treated with low doses of corticosteroids","volume":"2","author":"Tabarki","year":"1998","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0035","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10165-007-0610-y","article-title":"Dermatomyositis: clinical characteristics and the relatively high risk of interstitial lung disease","volume":"17","author":"Morinishi","year":"2007","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0040","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00296-005-0030-2","article-title":"Twelve years experience of juvenile dermatomyositis in North India","volume":"26","author":"Singh","year":"2006","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0045","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1346-8138.1992.tb03264.x","article-title":"Juvenile dermatomyositis: a statistical study of 114 patients with dermatomyositis","volume":"19","author":"Hiketa","year":"1992","journal-title":"J Dermatol"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0050","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.revmed.2007.03.004","article-title":"New classifications and pathophysiology of the inflammatory myopathies","volume":"28","author":"Benveniste","year":"2007","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0055","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/rheumatology\/kem265","article-title":"HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap","volume":"46","author":"Wedderburn","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0060","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1016\/S0140-6736(08)60955-1","article-title":"Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood","volume":"371","author":"Feldman","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0065","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jneuroim.2008.12.008","article-title":"Interferon alpha and neuromuscular disorders","volume":"207","author":"St\u00fcbgen","year":"2009","journal-title":"J Neuroimmunol."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0070","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8","article-title":"TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifi cations","volume":"43","author":"Pachman","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0075","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1002\/art.24039","article-title":"Cytokine gene polymorphisms as risk and severity factors for juvenile dermatomyositis","volume":"58","author":"Mamyrova","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0080","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/clim.2001.5212","article-title":"Increased plasma thrombospondin-1 (TSP-1) levels are associated with the TNF alpha-308A allele in children with juvenile dermatomyositis","volume":"103","author":"Lutz","year":"2002","journal-title":"Clin Immunol."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0085","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/art.22558","article-title":"Plasmacytoid dendritic cells in inflamed muscle of patients with juvenile dermatomyositis","volume":"56","author":"L\u00f3pez de Padilla","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0090","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00002281-200309000-00013","article-title":"Update on juvenile dermatomyositis: new advances in understanding its etiopathogenesis","volume":"15","author":"Wargula","year":"2003","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.autrev.2005.05.008","article-title":"Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis","volume":"5","author":"Sallum","year":"2006","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0100","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/00002281-200211000-00005","article-title":"Clinical outcomes in juvenile dermatomyositis","volume":"14","author":"Ramanan","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0105","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1056\/NEJMicm062850","article-title":"Images in clinical medicine. Gingival and periungual vasculopathy of juvenile dermatomyositis","volume":"360","author":"Rider","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0110","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1365-2133.2007.08055.x","article-title":"A systematic review of juvenile-onset clinically amyopathic dermatomyositis","volume":"157","author":"Gerami","year":"2007","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0115","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/art.24343","article-title":"Health-related quality of life of patients with juvenile dermatomyositis: results from the Pediatric Rheumatology International Trials Organisation multinational quality of life cohort study","volume":"61","author":"Apaz","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/art.23248","volume":"59","author":"Ruperto","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0125","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/rheumatology\/kel025","article-title":"Network for Juvenile Dermatomyositis, Paediatric Rheumatology European Society (PReS). An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM)","volume":"45","author":"Brown","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1749-6632.2009.04498.x","article-title":"MRI in juvenile idiopathic arthritis and juvenile dermatomyositis","volume":"1154","author":"Gardner-Medwin","year":"2009","journal-title":"Ann N Y Acad Sci."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0135","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.revmed.2005.02.002","article-title":"New diagnostic criteria and measuring outcome in polymyositis and dermatomyositis","volume":"26","author":"Ch\u00e9rin","year":"2005","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0140","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.md.0000173991.74008.b0","article-title":"Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients","volume":"84","author":"Troyanov","year":"2005","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0145","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/rheumatology\/kem359","article-title":"Clinical associations of autoantibodies to a p155\/140kDa doublet protein in juvenile dermatomyositis","volume":"47","author":"Gunawardena","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0150","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0155","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/art.23829","article-title":"The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis","volume":"59","author":"Seshadri","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0160","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1002\/art.23960","article-title":"Predicting the course of juvenile dermatomyositis: significance of early clinical and laboratory features","volume":"58","author":"Stringer","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0165","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2165\/00128072-200204050-00004","article-title":"Juvenile dermatomyositis: recognition and treatment","volume":"4","author":"Reed","year":"2002","journal-title":"Paediatr Drugs."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0170","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/01.bor.0000240362.32089.4c","article-title":"Advances in the treatment of juvenile dermatomyositis","volume":"18","author":"Stringer","year":"2006","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0175","first-page":"2498","article-title":"Intravenous immunoglobulin therapy for juvenile dermatomyositis: efficacy and safety","volume":"27","author":"Al-Mayouf","year":"2000","journal-title":"J Rheumatol."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0180","doi-asserted-by":"crossref","first-page":"e626","DOI":"10.1542\/peds.2007-1218","article-title":"Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content","volume":"121","author":"Manlhiot","year":"2008","journal-title":"Pediatrics."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0185","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s10067-008-0973-2","article-title":"Treatment of refractory juvenile dermatomyositis with tacrolimus","volume":"27","author":"Hassan","year":"2008","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.jbspin.2010.12.007_bib38","first-page":"727","article-title":"FK-506 in the treatment of unresponsive juvenile dermatomyositis (abs.)","volume":"59","author":"Modesto","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0195","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0025-7753(06)72367-3","article-title":"Efficacy of tacrolimus (FK-506) in the treatment of recalcitrant juvenile dermatomyositis: study of 6 cases","volume":"127","author":"Mart\u00edn Nalda","year":"2006","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0200","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/rheumatology\/ken074","article-title":"Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis","volume":"47","author":"Riley","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0205","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1002\/art.22856","article-title":"Rituximab for the treatment of juvenile dermatomyositis: a report of four pediatric patients","volume":"56","author":"Cooper","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbspin.2008.03.008","article-title":"Efficacy and safety of TNFalpha antagonist therapy in patients with juvenile spondyloarthropathies","volume":"76","author":"Sulpice","year":"2009","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0215","first-page":"1837","article-title":"Rapid improvement of calcinosis in juvenile dermatomyositis with alendronate therapy","volume":"32","author":"Ambler","year":"2005","journal-title":"J Rheumatol."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0220","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jbspin.2009.04.011","article-title":"Complete resolution of universal calcinosis in a patient with juvenile dermatomyositis using pamidronate","volume":"77","author":"Slimani","year":"2010","journal-title":"Joint Bone Spine."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0225","first-page":"28","article-title":"Les outils valid\u00e9s pour le suivi des dermatomyosites juv\u00e9niles","volume":"1","author":"Bughin","year":"2006","journal-title":"MT Pediatr"},{"key":"10.1016\/j.jbspin.2010.12.007_bib0235","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/art.1780261208","article-title":"Mortality from polymyositis and dermatomyositis in the United States, 1968\u20131978","volume":"26","author":"Hochberg","year":"1983","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jbspin.2010.12.007_bib0230","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpn.2006.11.004","article-title":"Childhood dermatomyositis associated with intracranial tumor and liver cysts","volume":"11","author":"Barisi\u0107","year":"2007","journal-title":"Eur J Paediatr Neurol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X10003350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X10003350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T07:26:16Z","timestamp":1543994776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X10003350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1297319X10003350"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2010.12.007","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}